Hantavirus: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
Line 3: Line 3:
 
*Enveloped, single-stranded RNA virus within the order [[Bunyavirales]], family [[Hantaviridae]]
 
*Enveloped, single-stranded RNA virus within the order [[Bunyavirales]], family [[Hantaviridae]]
 
*Acquired by inhalation of contaminated rodent urine or feces, and possibly by bites
 
*Acquired by inhalation of contaminated rodent urine or feces, and possibly by bites
  +
**In North America, it is carried by the [[deer mouse]] (most common in NA, transmits Sin Nombre), [[meadow vole]] (also present, transmits Prospect Hill), and white-footed mouse (also present, transmits New York); also [[cotton rat]], [[rice rat]], [[shrew]], and [[mole]]
 
*Essentially worldwide, though New World viruses tend to cause hantavirus pulmonary syndrome and Old World viruses tend to cause hemorrhagic fever with renal syndrome
 
*Essentially worldwide, though New World viruses tend to cause hantavirus pulmonary syndrome and Old World viruses tend to cause hemorrhagic fever with renal syndrome
**In Canada, no cases have been described east of Saskatchewan; specifically, no cases of HPS have been described in Ontario since it became reportable in 2001
+
**In Canada, no cases have been described east of Manitoba
  +
**No cases of HPS have been described in Ontario since it became reportable in 2001
  +
**About 4 or 5 new cases annually from southern rural parts of BC, Alberta, Saskatchewan, and Manitoba
 
*Incidence of HPS peaks in summer months (in North America)
 
*Incidence of HPS peaks in summer months (in North America)
   
Line 24: Line 27:
   
 
*Caused by New World hantaviruses such as Sin Nombre, Bayou, and Black Creek Canal
 
*Caused by New World hantaviruses such as Sin Nombre, Bayou, and Black Creek Canal
  +
*Incubation for 2 to 3 weeks
*Prodrome of fever followed 4 to 5 days later by shock and pulmonary edema
 
  +
*'''Prodromal phase'''
**Prodrome may include myalgias, abdominal pain, and gastrointestinal symptoms
 
  +
**Lasts 2 to 8 days
**Respiratory failure can develop quickly and often requires intubation
 
  +
**Nonspecific syndrome of fevers, chills, myalgias (including severe myalgias)
*Chest x-ray almost always shows bilateral infiltrates suggestive of [[ARDS]]
 
  +
**Continues to develop, with headache, vomiting, weakness, abdominal pain (can be severe), and sometimes diarrhea
*Elevated hematocrit (from third-spacing), leukocytosis, atypical lymphocytes, thrombocytopenia (with severity predicting mortality), prolonged PTT, and mild elevations in AST and LDH
 
  +
**Typically does not include upper respiratory symptoms, except cough and, in children, pharyngitis
  +
**Some strains can cause conjunctivitis, facial flushing, and a petechial rash
  +
**Thrombocytopenia is common, and can see elevated LDH
  +
*'''Cardiopulmonary phase'''
  +
**Characterized by capillary leak
  +
**Usually characterized by non-productive cough, with rapid onset of shock, coagulopathy, pulmonary edema (including [[ARDS]]), bronchorrhea, and arrhythmias
 
**Chest x-ray almost always shows bilateral infiltrates suggestive of [[ARDS]]
 
**Elevated hematocrit (from third-spacing), leukocytosis, atypical lymphocytes, thrombocytopenia (with severity predicting mortality), prolonged PTT, and mild elevations in AST and LDH
  +
***Triad of a left shift, lymphoid blasts >10%, and thrombocytopenia, is a helpful diagnostic triad
  +
*'''Oliguric and diuretic phases'''
  +
**Oliguria can last 3 to 7 days, followed by diuresis of variable duration
 
**Creatinine may be elevated, but not as severe as HFRS
 
**Creatinine may be elevated, but not as severe as HFRS
  +
*'''Convalescent phase'''
  +
**Initial recovery can be dramatically fast (over days), but complete recovery can be slow
 
*Case fatality rate is about 35%
 
*Case fatality rate is about 35%
   
Line 41: Line 57:
 
*PCR or immunohistochemical staining are both possible
 
*PCR or immunohistochemical staining are both possible
 
*Viral culture is difficult
 
*Viral culture is difficult
*Of note, it is a [[Biosafety risk groups|biosafety risk group]] 3 pathogen, which requires special precautions in the lab
+
*Of note, it is a '''[[Biosafety risk groups|biosafety risk group]] 3 pathogen''', which requires special precautions in the lab
  +
  +
=== HPS Case Definition (CDC) ===
  +
  +
* Clinical criteria
  +
** Fever greater than 38.3°C with prodrome of fever, chills, myalgia, headache, and GI symptoms, with one or more of:
  +
*** Bilateral diffuse interstitial edema
  +
*** Clinical diagnosis of [[ARDS]]
  +
*** Unexplained respiratory illness resulting in death where autopsy demonstrates noncardiogenic pulmonary edema
  +
*** Healthcare documentation listing a diagnosis of hantavirus pulmonary syndrome
  +
*** Death certificate listing hantavirus pulmonary syndrome
  +
* Laboratory criteria requires one of:
  +
** Reactive IgM, or rising titres of IgG
  +
** PCR/NAAT
  +
** Antigen by immunohistochemistry on biopsy
  +
* A confirmed case requires both clinical and laboratory criteria
   
 
==Management==
 
==Management==

Latest revision as of 13:54, 21 September 2023

Background

  • Enveloped, single-stranded RNA virus within the order Bunyavirales, family Hantaviridae
  • Acquired by inhalation of contaminated rodent urine or feces, and possibly by bites
    • In North America, it is carried by the deer mouse (most common in NA, transmits Sin Nombre), meadow vole (also present, transmits Prospect Hill), and white-footed mouse (also present, transmits New York); also cotton rat, rice rat, shrew, and mole
  • Essentially worldwide, though New World viruses tend to cause hantavirus pulmonary syndrome and Old World viruses tend to cause hemorrhagic fever with renal syndrome
    • In Canada, no cases have been described east of Manitoba
    • No cases of HPS have been described in Ontario since it became reportable in 2001
    • About 4 or 5 new cases annually from southern rural parts of BC, Alberta, Saskatchewan, and Manitoba
  • Incidence of HPS peaks in summer months (in North America)

Clinical Manifestations

  • Incubation period of 14 days (range 5 to 42 days)

Hemorrhagic Fever With Renal Syndrome (HFRS)

  • Caused by Old World hantaviruses, such as Hantaan, Dobrava, Seoul, Puumala, and other Old World hantaviruses
  • Fever, thrombocytopenia, and AKI caused by acute interstitial nephritis
  • Also headache, abdominal pain, low back pain, dizziness, and blurred vision
  • Can have conjunctival injection and petechiae on upper trunk and soft palate
  • Febrile phase lasts 4 to 7 days of acute, severe illness, followed by hypotensive, oliguric, and polyuric phases
  • Leukocytosis and thrombocytopenia seen on CBC
  • Mortality up to 5%

Hantavirus Pulmonary Syndrome (HPS)

  • Caused by New World hantaviruses such as Sin Nombre, Bayou, and Black Creek Canal
  • Incubation for 2 to 3 weeks
  • Prodromal phase
    • Lasts 2 to 8 days
    • Nonspecific syndrome of fevers, chills, myalgias (including severe myalgias)
    • Continues to develop, with headache, vomiting, weakness, abdominal pain (can be severe), and sometimes diarrhea
    • Typically does not include upper respiratory symptoms, except cough and, in children, pharyngitis
    • Some strains can cause conjunctivitis, facial flushing, and a petechial rash
    • Thrombocytopenia is common, and can see elevated LDH
  • Cardiopulmonary phase
    • Characterized by capillary leak
    • Usually characterized by non-productive cough, with rapid onset of shock, coagulopathy, pulmonary edema (including ARDS), bronchorrhea, and arrhythmias
    • Chest x-ray almost always shows bilateral infiltrates suggestive of ARDS
    • Elevated hematocrit (from third-spacing), leukocytosis, atypical lymphocytes, thrombocytopenia (with severity predicting mortality), prolonged PTT, and mild elevations in AST and LDH
      • Triad of a left shift, lymphoid blasts >10%, and thrombocytopenia, is a helpful diagnostic triad
  • Oliguric and diuretic phases
    • Oliguria can last 3 to 7 days, followed by diuresis of variable duration
    • Creatinine may be elevated, but not as severe as HFRS
  • Convalescent phase
    • Initial recovery can be dramatically fast (over days), but complete recovery can be slow
  • Case fatality rate is about 35%

Differential Diagnosis

Diagnosis

  • Serology usually positive by presentation (both IgM and IgG)
  • PCR or immunohistochemical staining are both possible
  • Viral culture is difficult
  • Of note, it is a biosafety risk group 3 pathogen, which requires special precautions in the lab

HPS Case Definition (CDC)

  • Clinical criteria
    • Fever greater than 38.3°C with prodrome of fever, chills, myalgia, headache, and GI symptoms, with one or more of:
      • Bilateral diffuse interstitial edema
      • Clinical diagnosis of ARDS
      • Unexplained respiratory illness resulting in death where autopsy demonstrates noncardiogenic pulmonary edema
      • Healthcare documentation listing a diagnosis of hantavirus pulmonary syndrome
      • Death certificate listing hantavirus pulmonary syndrome
  • Laboratory criteria requires one of:
    • Reactive IgM, or rising titres of IgG
    • PCR/NAAT
    • Antigen by immunohistochemistry on biopsy
  • A confirmed case requires both clinical and laboratory criteria

Management

  • Supportive